Clinical Trial Supplies Market 2020-2025: Catalent, Inc, Almac Group, Parexel International Corporation, Thermo Fisher Scientific, PCI Services, UDG Healthcare Plc, Biocair and Others.
According to Market Study Report, Clinical Trial Supplies Market provides a comprehensive analysis of the Clinical Trial Supplies market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. This report also provides market landscape and market share information in the Clinical Trial Supplies market.
Get Instant Sample Report in PDF Format @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=427439
The Clinical Trial Supplies Market is projected to reach USD 2.5 Billion by 2025 from USD 1.7 Billion in 2020, at a CAGR of 7.8%. This report spread across 158 Pages, Profiling 20 Companies and Supported with 132 Tables and 37 figures are now available in this research.
Top Key Players profiled in the Clinical Trial Supplies Market include are Catalent, Inc.(US),Almac Group (UK),Parexel International Corporation (US),Thermo Fisher Scientific, Inc. (US),PCI Services (US),UDG Healthcare Plc. (Ireland),Biocair (UK),Bilcare Limited (India),O&M Movianto (US),KLIFO A/S (Denmark),Capsugel (Switzerland),Infosys Limited (India),PRA Health Sciences, Inc. (US),Eurofins Scientific (Luxembourg),Marken (US),Seveillar Clinical Trial Supplies Pvt. Ltd. (India),N-SIDE (Belgium).
“Logistics services segment to account for the largest share of the clinical trial supplies market in 2020”
Based on service, the clinical trial supplies market is segmented into logistics; distribution, storage, and retention; packaging, labeling, and blinding; manufacturing; comparator sourcing; and solutions. The logistics services segment is expected to account for the largest share of the clinical trial supplies market during the forecast period. This can primarily be attributed to the globalization of clinical trials and the increasing number of trials involving temperature-sensitive products.
Coupon Code Available for 20% Discount @ https://www.reportsnreports.com/purchase.aspx?name=427439
“Oncology segment to account for the largest share of the clinical trial supplies market, by therapeutic area, in 2020”
Based on the therapeutic area, the clinical trial supplies market is segmented into oncology, neurological and mental disorders, infectious and immune system diseases, digestive system diseases, blood disorders, and other therapeutic areas. The oncology segment is expected to account for the largest share of the market in 2020 and is estimated to register the highest growth during the forecast period majorly due to the high and growing number of research studies on cancer therapeutics and a large number of companies focusing on bringing innovative cancer drugs to the market.
“North America will continue to dominate the clinical trial supplies market during the forecast period”
In 2020, North America is estimated to be the largest regional market for clinical trial supplies, followed by Europe. The presence of well-established CROs and the high and growing investments in drug discovery and development by pharmaceutical and biopharmaceutical companies in North America are the major factors responsible for the large share of this region in the global market.
Competitive Landscape of Clinical Trial Supplies Market:
2 Market Share Analysis, 2018
3 Competitive Scenario
3.1 Service Launches
3.2 Agreements and Collaborations
3.5 Other Developments
4 Competitive Leadership Mapping (2019)
4.1 Vendor Inclusion Criteria
4.2 Visionary Leaders
4.4 Dynamic Differentiators
4.5 Emerging Companies
Reason to access this report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall clinical trial supplies market and its sub segments.It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies.